Breaking News, Promotions & Moves

Lilly CEO Returns

Lechleiter makes recovery from heart surgery

By: Gil Roth

President, Pharma & Biopharma Outsourcing Association

John C. Lechleiter, Ph.D., has returned to his duties as chairman, president, and chief executive officer of Eli Lilly & Co. Dr. Lechleiter has been on medical leave since his scheduled surgery for a dilated aorta on May 13, 2013. His surgery and recovery were successful and he has been cleared by his personal physician and the company’s employee health services physician to return to full-time work. “I am overwhelmed and humbled by the tremendous support and well-wishes I have ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters